Portfolio company
EpiHeart
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops cardiac cell therapy devices for heart failure treatment, intended for use by surgeons during cardiac surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CardioPrecision
This company develops medical devices and robotic platforms for transcervical access and cardiothoracic surgery for healthcare providers and surgical teams.
Heartseed
Heartseed develops cell-based regenerative therapies and transplantation devices for patients with severe heart failure and other cardiac diseases.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Vascular Graft Solutions
This company develops external support devices and surgical tools for vein grafts to improve outcomes in coronary and peripheral bypass surgeries for cardiac surgeons.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Cardiac Success Ltd.
This company develops a transcatheter ventricular repair device to treat patients suffering from heart failure with reduced ejection fraction.
CardiacBooster
This medical device company develops percutaneous ventricular assist devices for patients suffering from cardiogenic shock or undergoing high-risk coronary procedures.
BioVentrix®
This medical device company develops minimally invasive therapies for cardiothoracic surgeons to treat heart failure by restoring the shape of the left ventricle.
